Dyslipidemia clinical trials
32 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
- Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
- A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4954 in Healthy Adult Participants With or Without Elevated Lipoprotein (a) (Lp[a]) Levels, and Participants With Dyslipidemia
- PILI 'Āina Household
- Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
- 'Ai Pono Cooking Demonstrations
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Targeting Metabolic Syndrome From the Emergency Department Through Mixed-Methods: Pilot Trial
- Intermittent Cottonseed Oil Consumption
- Evaluation of Milk Polar Lipids in Dyslipidemic Adults With Abdominal Obesity
- Cottonseed Oil Versus Matched PUFA Effects
- Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults
- Natural History of Uncommon Dyslipidemias, Rare Lipid Disorders and Unusual Atherosclerotic Conditions
- Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for PLWH in the SE US
- Gut Microbiota in Metabolic Surgery
- Causes and Natural History of Dyslipidemias
- Metabolic Responses to Bariatric Surgery
- A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors
- Understanding Decentralized Trial Engagement and Clinical Impediments Through Digital Efforts (UDECIDE) Among Unrepresented Groups With Poor Cardiovascular and Cardiometabolic Health
- Atlantic Lipid Lowering Treatment Optimization Program
- Reducing Inflammation to Improve Vascular and Bone Outcomes With Low-dose Colchicine in CKD
- Impact of a Produce Prescription Program and Nutrition Education Intervention on Cardiovascular Health in Youth
- Cardiometabolic Effects of the Recommended Daily Pecan Intake Dose
- A Study of VV-14303 for the Treatment of Metabolic Dysfunction-associated Steatohepatitis (MASH)
- Household Participants
- Implementation Facilitation of Exercise is Medicine Greenville
- To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years
- Improving Cardiovascular Health Risks in Adults With Epilepsy on a Modified Atkins Diet
- Patient-engaged Development and Testing of Educational Content on Side Effects of Statins
- Evaluation of a Primary Care Based Lifestyle Medicine Clinic at UAB
- Dietary Supplementation on Body Fat Composition
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Dyslipidemia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.